Published in Support Care Cancer on April 01, 2010
Atrial fibrillation and stroke associated with intravenous bisphosphonate therapy in older patients with cancer. J Clin Oncol (2010) 1.48
A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events. Breast Cancer Res Treat (2014) 0.93
Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study. Br J Cancer (2011) 0.82
Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements. J Cardiovasc Electrophysiol (2015) 0.79
Efficacy of zoledronic acid in treatment of osteoporosis in men and women-a meta-analysis. Int J Clin Exp Med (2015) 0.75
Inflammation and cancer. Nature (2002) 53.78
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med (2007) 9.83
C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation (2001) 5.49
Corticosteroids and the risk of atrial fibrillation. Arch Intern Med (2006) 3.28
Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med (2008) 2.66
Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J (1983) 1.61
Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene. Menopause (2010) 1.57
Preventing fractures in elderly people. BMJ (2003) 1.57
Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ (2008) 1.54
Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases. Clin Cancer Res (2003) 1.29
Systemic and peritoneal inflammatory response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial. Dis Colon Rectum (2003) 1.18
Atrial fibrillation in fracture patients treated with oral bisphosphonates. J Intern Med (2009) 1.03
Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis. PLoS One (2009) 1.01
Relation of bisphosphonate therapies and risk of developing atrial fibrillation. Am J Cardiol (2009) 0.99
Cardiac toxicity with anti-HER-2 therapies: what have we learned so far? Target Oncol (2009) 0.98
Drug-induced atrial fibrillation. J Am Coll Cardiol (2004) 0.94
Atrial fibrillation in chronic non-cardiac disease: where do we stand? Int J Cardiol (2008) 0.90
First diagnosis of colorectal or breast cancer and prevalence of atrial fibrillation. Intern Emerg Med (2008) 0.88
Systemic inflammation, atrial fibrillation, and cancer. Circulation (2002) 0.84
Prevalence and predictors of new-onset atrial fibrillation after elective surgery for colorectal cancer. Pacing Clin Electrophysiol (2005) 0.77
Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma (2007) 2.55
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res (2008) 2.42
Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study. J BUON (2015) 1.97
Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J Clin Oncol (2009) 1.60
Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature. Expert Opin Ther Targets (2010) 1.48
Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis. Med Hypotheses (2004) 1.42
Manipulating the chemokine-chemokine receptor network to treat cancer. Cancer (2007) 1.38
Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer. Med Oncol (2010) 1.16
Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient. World J Gastroenterol (2006) 1.10
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. Leuk Lymphoma (2009) 1.09
EGFR expression and gene copy number in triple-negative breast carcinoma. Cancer Genet Cytogenet (2010) 1.08
Association between common risk factors and molecular subtypes in breast cancer patients. Breast (2012) 1.06
Unusual location of hydatid cyst: soft tissue mass in the neck. Eur Arch Otorhinolaryngol (2006) 1.01
Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors. J Oral Maxillofac Surg (2006) 1.00
Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Cancer Invest (2007) 1.00
Outcome of non-metastatic male breast cancer: 118 patients. Med Oncol (2011) 0.99
Cardiotoxicity of novel HER2-targeted therapies. Curr Med Res Opin (2013) 0.97
Metastatic granular cell tumor: a case report and review of the literature. Acta Oncol (2006) 0.97
From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures. Eur J Cancer Prev (2008) 0.96
Stem cell-related markers in primary breast cancers and associated metastatic lesions. Mod Pathol (2012) 0.95
Systemic treatment in breast-cancer patients with brain metastasis. Expert Opin Pharmacother (2010) 0.95
Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients? Acta Oncol (2006) 0.94
A case report: zoledronic acid-induced anterior uveitis. Med Oncol (2007) 0.94
Pertuzumab in HER2-positive breast cancer. Curr Med Res Opin (2012) 0.94
Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma. Med Oncol (2010) 0.94
Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer. Curr Med Res Opin (2013) 0.93
Metaplastic breast carcinoma: a heterogeneous disease. Asian Pac J Cancer Prev (2014) 0.92
Breast cancer subtypes and outcomes of central nervous system metastases. Breast (2011) 0.92
Hormone receptor status in patients with breast cancer and liver metastases treated with laser-induced intersititial thermotherapy. Radiology (2005) 0.91
Anterior abdominal wall synovial sarcoma: a rare presentation. Am J Clin Oncol (2005) 0.91
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. Breast Cancer Res (2007) 0.91
Warfarin-induced skin necrosis and leukocytoclastic vasculitis in a patient with acquired protein C and protein S deficiency. Blood Coagul Fibrinolysis (2007) 0.90
Characteristics of breast cancer patients with central nervous system metastases: a single-center experience. J Natl Med Assoc (2008) 0.90
Brain metastasis of cardiac myxoma: case report and review of the literature. J Neurooncol (2005) 0.90
Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma. Med Oncol (2008) 0.90
Possible association between nanobacteria and malignant microcalcifications in breast cancer. Breast J (2006) 0.89
Orbital metastasis from adenocarcinoma of the colon. South Med J (2005) 0.88
Trastuzumab in metastatic breast cancer after complete remission: How long is enough? Med Oncol (2015) 0.88
Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer. Med Oncol (2010) 0.88
Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients. Oncology (2013) 0.87
Cutaneous metastases of signet cell carcinoma of the rectum without accompanying visceral involvement. South Med J (2006) 0.87
Optimal timing of adjuvant treatment in patients with early breast cancer. Med Oncol (2010) 0.87
Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metformin. Med Oncol (2013) 0.86
Ductal carcinoma in situ and bilateral atypical ductal hyperplasia in a 23-year-old man with gynecomastia. Am Surg (2011) 0.86
Treatment and outcomes of Ewing sarcoma in Turkish adults: a single centre experience. Asian Pac J Cancer Prev (2014) 0.86
Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes. Med Oncol (2013) 0.86
Doxorubicin-induced second degree and complete atrioventricular block. Europace (2005) 0.86
Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension. Ann Pharmacother (2006) 0.85
Leptin and breast cancer: an overview. Med Oncol (2011) 0.84
Preoperative Doppler sonography for prevention of perioperative stroke in head and neck cancer patients undergoing neck dissection: is it beneficial? J Clin Ultrasound (2007) 0.84
Demographic and clinico-pathological characteristics of breast cancer patients with history of oral alendronate use. Med Oncol (2012) 0.84
Herpes simplex type-2 encephalitis masked by diabetic ketoacidosis. J Natl Med Assoc (2005) 0.84
Blood ABO groups and risk of breast cancer. Med Oncol (2010) 0.84
Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer. Med Oncol (2007) 0.84
Impact of inflammatory markers on the prognosis of patients with operable breast cancer. J BUON (2014) 0.84
Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient. Ann Pharmacother (2005) 0.84
The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach. Cancer (2004) 0.84
Treatment of recurrent cerebellar hemangioblastoma with external radiotherapy in a patient with von Hippel-Lindau disease: a case report and review of the literature. J Neurooncol (2005) 0.84
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy. Urol Oncol (2012) 0.83
Pharmacotherapy of triple-negative breast cancer. Expert Opin Pharmacother (2009) 0.83
Isolated granulocytic sarcoma of the head and neck preceding acute myeloid leukemia. Am J Hematol (2004) 0.83
Interleukin-6 and C-reactive protein in metastatic renal cell carcinoma. J Clin Oncol (2005) 0.83
Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases. Med Oncol (2008) 0.82
Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C. Eur J Haematol (2008) 0.82
Clinical characteristics and outcome of patients with stage III esophageal carcinoma: a single-center experience from Turkey. Med Oncol (2007) 0.82